CTOs on the Move

TruVision

www.truvision.com

 
TruVision is a South Jordan, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.truvision.com
  • 859 W South Jordan Pkwy
    South Jordan, UT USA 84095
  • Phone: 888.929.2020

Executives

Name Title Contact Details

Similar Companies

Lumo Bodytech

Lumo Bodytech has developed a technology platform that leverages smart sensors and software to optimize performance and address human biomechanics through the real-time tracking of body movement. Lumo’s products empower you to be the best version of yourself. Current Lumo Bodytech products include the Lumo Lift and Lumo Back posture coaches and activity trackers, as well as the Lumo Run smart running shorts.

Medical Device Manufacturers Association

Medical Device Manufacturers Association is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

New York State Office of Mental Health

New York State Office of Mental Health is a Albany, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Shared Health Svc

Shared Health Svc is a La Crosse, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ion Beam Applications

IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The Company is the worldwide technology leader in the field of proton therapy, the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room systems. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1200 people worldwide, IBA has installed systems across the world, from Europe and the US and to the emerging markets.